ASH 2021

Conference Coverage

Geriatric Assessment Better Than Chronologic Age for Measuring Health-Related Quality of Life in NHL

By

John Schieszer

A prospective study sought to determine the value of geriatric assessment in patients with non-Hodgkin lymphoma, compared with assessment based on chronological age.

Patient Perspective on Their Prognosis Affects QOL, Psychological Distress in MM

By

John Schieszer

This study investigated the effects of patients’ perceptions of their disease status and prognosis on quality of life and psychological distress.

Analysis Defines Impact of Frailty on Outcomes in Lymphoma

By

John Schieszer

Researchers conducted a secondary analysis of data from the phase 3 LY.12 clinical trial to measure effect of frailty on outcomes for patients with lymphoma.

Less Intensive Monitoring of Venetoclax May be Safe in Low-Risk CLL

By

John Schieszer

A retrospective review of data from patients with CLL demonstrated varied adherence to guidelines for ramp up initiation and laboratory monitoring.

ACE-27 Score Has Prognostic Potential in Chronic Phase Chronic Myeloid Leukemia

By

John Schieszer

A retrospective review demonstrated that higher Adult Comorbidity Evaluation 27 scores are prognostic for poorer outcomes in patients with CML.